132 related articles for article (PubMed ID: 10718210)
21. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
[TBL] [Abstract][Full Text] [Related]
22. ESPL1 is a candidate oncogene of luminal B breast cancers.
Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
[TBL] [Abstract][Full Text] [Related]
23. p53 mutations in benign breast tissue.
Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ
J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086
[TBL] [Abstract][Full Text] [Related]
24. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
[TBL] [Abstract][Full Text] [Related]
26. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
27. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the RON gene in human breast carcinoma.
Maggiora P; Marchio S; Stella MC; Giai M; Belfiore A; De Bortoli M; Di Renzo MF; Costantino A; Sismondi P; Comoglio PM
Oncogene; 1998 Jun; 16(22):2927-33. PubMed ID: 9671413
[TBL] [Abstract][Full Text] [Related]
29. Expression analysis of cystatin C and M in laser-capture microdissectioned human breast cancer cells--a preliminary study.
Vigneswaran N; Wu J; Muller S; Zacharias W; Narendran S; Middleton L
Pathol Res Pract; 2005; 200(11-12):753-62. PubMed ID: 15792117
[TBL] [Abstract][Full Text] [Related]
30. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
[TBL] [Abstract][Full Text] [Related]
31. High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
Egawa C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Int J Cancer; 2002 Apr; 98(6):879-82. PubMed ID: 11948466
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2002 Mar; 98(3):415-8. PubMed ID: 11920593
[TBL] [Abstract][Full Text] [Related]
33. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
[TBL] [Abstract][Full Text] [Related]
34. [Expression of vascular endothelial growth factor receptor 3 in human breast cancer and its significance].
Wu J; Chen L; Zhou W; Liu X; Chen X; Miao D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Dec; 27(12):1487-91. PubMed ID: 24640372
[TBL] [Abstract][Full Text] [Related]
35. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
36. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
37. Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue.
Orlando C; Raggi CC; Bianchi S; Distante V; Simi L; Vezzosi V; Gelmini S; Pinzani P; Smith MC; Buonamano A; Lazzeri E; Pazzagli M; Cataliotti L; Maggi M; Serio M
Endocr Relat Cancer; 2004 Jun; 11(2):323-32. PubMed ID: 15163307
[TBL] [Abstract][Full Text] [Related]
38. Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers--a molecular study of 59 patients.
Ghaffari SR; Sabokbar T; Tahmasebi S; Dastan J; Shorakae S; Moradi A; Tirgari F; Mohagheghi MA; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2006; 7(3):396-8. PubMed ID: 17059329
[TBL] [Abstract][Full Text] [Related]
39. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
40. [Study of HOXA5 gene expression in breast carcinoma].
Zeng Y; Yang WT; Zhang GH; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):569-74. PubMed ID: 16468307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]